572 related items for PubMed ID: 3000118
21. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B, Bochicchio D, Fadin C, Colombo P, Faglia G.
J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
[Abstract] [Full Text] [Related]
22. Unpredictable hypersecretion of cortisol in Cushing's disease: detection by daily salivary cortisol measurements.
Hermus AR, Pieters GF, Borm GF, Verhofstad AA, Smals AG, Benraad TJ, Kloppenborg PW.
Acta Endocrinol (Copenh); 1993 May; 128(5):428-32. PubMed ID: 8391195
[Abstract] [Full Text] [Related]
23. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME, Orth DN, Halmi NS, Zielinski AC, Davis DR, Chavez FT, Drucker WD.
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[Abstract] [Full Text] [Related]
24. Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome.
Coiro V, Volpi R, Capretti L, Caffarri G, Chiodera P.
J Intern Med; 2000 Jun; 247(6):667-73. PubMed ID: 10886488
[Abstract] [Full Text] [Related]
25. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.
Kuwayama A, Kageyama N, Nakane T, Watanabe M, Kanie N.
J Clin Endocrinol Metab; 1981 Jul; 53(1):165-73. PubMed ID: 6263935
[Abstract] [Full Text] [Related]
26. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
Schteingart DE, McKenzie AK.
J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
[Abstract] [Full Text] [Related]
27. Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection.
Peri A, Bemporad D, Parenti G, Luciani P, Serio M, Mannelli M.
Eur J Endocrinol; 2001 Nov; 145(5):605-11. PubMed ID: 11720879
[Abstract] [Full Text] [Related]
28. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[Abstract] [Full Text] [Related]
29. Cyclic Cushing's disease with paradoxical response to dexamethasone.
Checchi S, Brilli L, Guarino E, Ciuoli C, Di Cairano G, Mazzucato P, Pacini F.
J Endocrinol Invest; 2005 Sep; 28(8):741-5. PubMed ID: 16277172
[Abstract] [Full Text] [Related]
30. Nyctohemeral variation and suppressibility of plasma ACTH in various stages of Cushing's disease.
Cook DM, Kendall JW, Allen JP, Lagerquist LG.
Clin Endocrinol (Oxf); 1976 Jul; 5(4):303-12. PubMed ID: 183922
[Abstract] [Full Text] [Related]
31. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[Abstract] [Full Text] [Related]
32. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
Tanaka T, Hibi I, Shimizu N, Imura H, Tanaka K, Fukata J, Fujieda K, Ichimura T, Kuribayashi T, Ito K.
Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
[Abstract] [Full Text] [Related]
33. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
Streeten DH, Anderson GH, Brennan S, Jones C.
J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
[Abstract] [Full Text] [Related]
34. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[Abstract] [Full Text] [Related]
35. Endocrine function in patients with Cushing's disease before and after treatment.
Lindholm J.
Clin Endocrinol (Oxf); 1992 Feb; 36(2):151-9. PubMed ID: 1314723
[Abstract] [Full Text] [Related]
36. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
Müller OA, Stalla GK, von Werder K.
Horm Res; 1987 Feb; 25(4):185-98. PubMed ID: 3034758
[Abstract] [Full Text] [Related]
37. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Müller OA.
J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
[Abstract] [Full Text] [Related]
38. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
Krieger DT, Allen W.
J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
[Abstract] [Full Text] [Related]
39. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[Abstract] [Full Text] [Related]
40. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
